Autoimmune Pancreatitis clinical trials
The registry lists 28 studies for Autoimmune Pancreatitis across 8 countries. 7 are recruiting or about to start. 19 of them are mainly about Autoimmune Pancreatitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Autoimmune Pancreatitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Peking Union Medical College Hospital (5) · Ruijin Hospital (3) · Huazhong University of Science and Technology (3) · Mayo Clinic (2) · Johns Hopkins University (2) · Massachusetts General Hospital (1) · Military Medical Clinical Center of the Southern Region, Ukraine (1) · Bin Cheng (1)
What is being tested here
Drugs under test in Autoimmune Pancreatitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Inebilizumab | 1 | 0 | 1 |
| Mycophenolic Acid | 1 | 0 | 1 |
| Rituximab | 0 | 0 | 2 |
| Lenalidomide | 0 | 0 | 1 |
Who these studies take
Of the 4 Autoimmune Pancreatitis studies recruiting now, 3 (75%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 4 (100%) | 4 (100%) |
| 30 | 4 (100%) | 4 (100%) |
| 40 | 4 (100%) | 4 (100%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 4 (100%) | 4 (100%) |
| 85 | 3 (75%) | 3 (75%) |
Across all 28 studies, recruiting or not: 11% stop at 75 or younger and 4% at 65; 11% take children; 0% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 14, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 28 of 28. search them.
- AI-Assisted Differentiation of Autoimmune Pancreatitis and Pancreatic Cancer Using Endoscopic UltrasoundNot yet recruitingNCT07900776
- Inebilizumab for the Treatment of Patients With Type 1 Autoimmune PancreatitisRecruitingNCT07862075Phase 41 country
- A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of RecurrenceRecruitingNCT06468709Phase 41 country
- Validation of the Odesa Criteria 2026 for Autoimmune PancreatitisRecruitingNCT075368411 country
- Validation of Joint-AI in Diagnosing Pancreatic Solid LesionsNot yet recruitingNCT06753318Not applicable1 country
- Study on AI-assisted Multimodal Diagnosis System of Autoimmune PancreatitisRecruitingNCT063699091 country
- Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR)Not yet recruitingNCT06328101
- EchoTip AcuCore Post-Market Clinical StudyCompletedNCT063580011 country
- To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic UltrasoundCompletedNCT048345051 country
- Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune PancreatitisCompletedNCT043977312 countries
- CT Findings in Surgically Treated Focal Pancreatic Disease- A Retrospective StudyCompletedNCT06699667
- Artificial Intelligence in EUS for Diagnosing Pancreatic Solid LesionsCompletedNCT054769781 country
- Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/BiopsyCompletedNCT051715171 country
- A Real-world Comparison of FNB and FNA in IHC-required Lesions.CompletedNCT055650661 country
- EUS Shear Wave for Solid Pancreatic Lesions.Status unknownNCT050958311 country
- Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune PancreatitisStatus unknownNCT03753815Not applicable1 country
- Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by CorticosteroidsStatus unknownNCT02797665Not applicable1 country
- Treatment of IgG4-Related Disease With Revlimid and RituximabCompletedNCT02705638Phase 11 country
- Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor GeneStatus unknownNCT03830073
- Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune PancreatitisWithdrawnNCT018454671 country
- Evaluation of EUS-guided FNA for Diagnosing Autoimmune PancreatitisCompletedNCT03241797Not applicable1 country
- Rituximab in IgG4-RD: A Phase 1-2 TrialCompletedNCT01584388Phase 1/2
- Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)WithdrawnNCT02766842Phase 21 country
- Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR PancreatographyCompletedNCT017730311 country
- Follow-up Study of Complications of Acute PancreatitisStatus unknownNCT023059141 country
- CT Pancreas PerfusionCompletedNCT005883671 country
- EUS-guided Procore-biopsy in Diagnosing Autoimmune PancreatitisStatus unknownNCT01774513Not applicable1 country
- Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)CompletedNCT004444441 country